ArticleOPEN ACCESS

Too much ara-C? Not enough daunorubicin?

Blood
DOI: 10.1182/blood-2011-01-328633
7Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It seems strange, but after 40 years of experience using cytosine arabinoside (ara-C) and daunorubicin, leukemia doctors are still unsure as to how much of each drug they should use to treat their patients with acute myeloid leukemia (AML).

Cite

CITATION STYLE

APA

Feldman, E. J. (2011, February 24). Too much ara-C? Not enough daunorubicin? Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-01-328633

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free